Q&A Session: Discussing How to Prepare for & Pursue the Accelerated Approval Pathway for Rare & Genetic Kidney Diseases
Time: 11:30 am
day: Conference Day Two
Details:
- This is your opportunity to prepare your burning questions for this dynamic Q&A session with the FDA on accelerated approval pathways for drug candidates in the rare renal space!
